A court has rejected a bid to expand a lawsuit over a Chinese investor’s $27.5 million contract to purchase a building at 99 Queen Street in Melbourne to join the matriarch of the “very wealthy” family.
Spanish multinational electrical giant Iberdrola has been selected to design and operate the Victoria to New South Wales Interconnector West transmission project, part of the state’s pipeline of new energy infrastructure projects. As the winner of the competitive tender process, Iberdrola will work with government-owned VicGrid on designing and developing the project, which will link…
A judge has tossed a developer’s challenge to a NSW Heritage Council decision on a new residential development plan for the site of the former Kenmore Hospital in Goulburn, saying there was no decision to appeal.
Lander & Rogers has recruited a competition law expert from Herbert Smith Freehills Kramer for its corporate team ahead of the new merger review regime.
ASIC on Thursday pushed for penalties totalling $85 million against Harvey Norman and Latitude Finance, after an appeals court found the retailer’s ads touting interest-free financing were misleading.
The trustee for super fund Cbus has agreed to pay a $23.5 penalty after admitting liability in the corporate regulator’s case over excessive delays in processing $20 million in death and disability claims.
The owner of Sydney developer Coronation Property has sued Fairfax for defamation over a Sydney Morning Herald story that allegedly linked him to arson attacks on two childcare centres and the home of YouTuber Jordan Shanks.
A judge has approved a “modest” $8.7 million settlement in a class action against medical device maker Exactech over allegedly defective joint replacements, saying the settlement was fair and reasonable given the limited assets of the company, whose parent has filed for bankruptcy in the US.
A former managing director of ratings agency Nielsen, who alleges she was unfairly dismissed after her husband was fired from the company, has lost her bid to be temporarily reinstated.
Mayne Pharma has secured an extension of the deadline for securing Foreign Investment Review Board approval of its $672 million tie-up with US drug maker Cosette.